Quarterly report pursuant to Section 13 or 15(d)

12. Segment and Geographic Information

v3.20.2
12. Segment and Geographic Information
3 Months Ended
Jun. 30, 2020
Segment Reporting [Abstract]  
Segment and Geographic Information

Note 12. Segment and Geographic Information

 

The Company generates revenues from products which are sold into the human and animal healthcare markets.

 

The following table shows the Company’s revenues by geographic region:

 

    Three Months Ended June 30,  
    2020     2019  
United States   $ 1,620,000     $ 2,487,000  
Latin America     2,327,000       764,000  
Europe and Rest of the World     1,820,000       1,244,000  
Total   $ 5,767,000     $ 4,495,000